Official Title
Interaction of Genomic and Dietary Aspects in Gastric Cancer Risk: the Global StoP Project
Brief Title
Genomic and Dietary Aspects in Gastric Cancer Risk
Protocol ID
NCT05934058
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary
Gastric Cancer (GC) ranks fourth in the number of deaths worldwide and it is sixth in
Italy with almost 9,000 deaths in 2020. Survival of GC is one of the lowest reported
amongst major cancers, thus making prevention a central priority for its control. However
there is currently a lack of evidence on gastric cancer determinants.
Our study will pursue the following specific objectives:
- analyze dietary and lifestyle habits for GC, also infrequent ones (WP1);
- analyze major risk factors in rare patient subgroups (WP2);
- develop a Genome-wide Modelling of polygenic risk score (PRS) in GC (WP3)
Detailed Description
The Stomach cancer Pooling project (StoP) Consortium dataset has grown to the current
number of 35 studies from Europe, America, Middle East and Eastern Asia. It will be used
as the cornerstone upon which the investigation on the dietary and lifestyle determinants
of gastric cancer (GC) will be built. It will allow the analyses of relatively infrequent
habits or exposures, genetic factors as well as to perform sufficiently powered analyses
of interactions and subgroups that may present relevant heterogeneity in the etiological
correlates of GC.
The potential of genomics to personalize and thereby improve diagnosis, treatment, and
prognosis of individuals has long been recognized, but so far evidence of the opportunity
for genomics to drive prevention remains limited. Recent advances in research on
Polygenic Risk Score (PRS) have created new interest about the use of genetic information
in prevention of common diseases and its application to risk stratification. A
long-lasting open question is whether common genetic variants used to build PRS are able
to predict the risk of developing complex diseases with enough power to be used in a
clinical setting.
The lack of large enough dataset able to allow an unbiased PRS validation, hampered this
question to be answered for many years. This study builds upon the StoP project (a
consortium collecting data from about 13,500 GC cases and 32,000 controls) and the UK
Biobank (480 GC cases and 338,000 controls) to develop a Polygenic Risk Score for gastric
cancer.
Study Period
-
Enrollment Count
383,980 participants
Eligibility Criteria
Inclusion Criteria:
- Patients participating in studies that collaborate with the StoP Project
- Patient enrolled by the UK Biobank
Exclusion Criteria:
- Age <18 years old
- Studies with less than 80 cases of histologically confirmed Gastric Cancer
Filters
Gastric Cancer
NOT_YET_RECRUITING
ADULT
OLDER_ADULT